First test: how a new drug behaves in damaged kidneys
NCT ID NCT07012005
Summary
This early study aimed to understand how a drug called BPN14770 is processed by the body in people with severe kidney impairment. It compared 14 participants—some with healthy kidneys and some with severe kidney problems—to see how the drug's levels in the blood differed between the two groups. The main goal was to gather basic safety and dosing information for future research.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Division of Clinical Pharmacology, University of Miami
Miami, Florida, 33136, United States
-
Orlando Clinical Research Center
Orlando, Florida, 32809, United States
Conditions
Explore the condition pages connected to this study.